Intra-anesthetic Problems - Malignant Hyperthermia

Intra-anesthetic Problems - Malignant Hyperthermia is a topic covered in the Clinical Anesthesia Procedures.

To view the entire topic, please or purchase a subscription.

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Explore these free sample topics:

Anesthesia Central

-- The first section of this topic is shown below --

Etiology

Etiology. Malignant hyperthermia is a hypermetabolic syndrome occurring in genetically susceptible patients after exposure to an anesthetic triggering agent. Triggering anesthetics include all potent inhalational agents (e.g., halothane, isoflurane, desflurane, and sevoflurane) and succinylcholine. The syndrome is thought to be due to a reduction in the reuptake of Ca2+ by the sarcoplasmic reticulum necessary for the termination of muscle contraction. Consequently, muscle contraction is sustained, resulting in signs of hypermetabolism, including tachycardia, acidosis, hypercarbia, muscle rigidity, tachypnea, hypoxemia, and hyperthermia. Malignant hyperthermia usually occurs in the operating room but onset may be delayed until the patient reaches the postanesthesia care unit or even the postoperative floor.

-- To view the remaining sections of this topic, please or purchase a subscription --